Murray A. Raskind, MD
VA Puget Sound Health Care System Seattle Division, Seattle, WA · University of Washington/Department of Veterans Affairs
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Murray A. Raskind, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:50 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT03221751 · Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI)VA Office of Research and Development · terminated · Dementia · principal investigator
- Ph4NCT02965027 · Prazosin for Post-Concussive HeadachesSeattle Institute for Biomedical and Clinical Research · completed · Post-Traumatic Headache
- Ph3NCT00532493 · Cooperative Studies Program #563 - Prazosin and Combat Trauma PTSDVA Office of Research and Development · completed · PTSD, Sleep Disorders · study chair
- N/ANCT00183430 · Prazosin for Treating Noncombat Trauma Post-Traumatic Stress DisorderSeattle Institute for Biomedical and Clinical Research · terminated · Post-Traumatic Stress Disorder, Sleep Initiation and Maintenance Disorders · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Prazosin and CSF Biomarkers in mTBII21RX002180 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI MURRAY A RASKIND · fiscal years 2016 to 2017Named on NCT03221751
- Prazosin for Noncombat Trauma PTSDR01MH069867 · NIMH · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI MURRAY A RASKIND · fiscal years 2005 to 2008Named on NCT00183430
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:50 UTC. The ranking covers the 200 most relevant of 8 PubMed records, and a shared surname and initials can bring in a namesake. All 8 on PubMed
- Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.N Engl J Med · 2015797 citationsRCR 34.2
- Delayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementation.Nat Commun · 2018171 citationsRCR 7.0
- Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.Nat Med · 2021146 citationsRCR 9.4
- Avapritinib versus Placebo in Indolent Systemic Mastocytosis.NEJM Evid · 202375 citationsRCR 9.6
- GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe.Alzheimers Res Ther · 202424 citationsRCR 3.7
- 18 citationsRCR 2.2
- 13 citationsRCR 0.9
- Association of non-steroidal anti-inflammatory medications and aspirin with colorectal cancer incidence in older adults.J Natl Cancer Inst · 20251 citationsRCR 0.3